Journal Article

Abnormal generation of IL-17A represses tumor infiltration of stem-like exhausted CD8+ T cells to demote the antitumor immunity

Zhao, Fei, Zhang, Ruochan, Li, Xing-Ning, Wang, Dongmei, Gong, Caifeng, Xu, Chungui, Wu, Zhiyuan, Qu, Chunfeng, Chen, Kun, Cai, Jianqiang, Zhou, Aiping

2023

Overview

Background Variated anti-cancer therapies are combined with immune checkpoint blockades (ICBs) for improving ICB therapeutic efficacy. Occurrence of tissue damage is common that triggers multiple inflammatory cytokine generation. Gastrointestinal organs are the commonly affected. We investigated the impact of acute colitis on tumor infiltration of antigen-specific CD8 + cytotoxic T lymphocytes (CTLs) for controlling tumor growth and responding to antibody against PD-1 (anti-PD-1). Methods Several tumor cell lines were inoculated into syngeneic mice subcutaneously or intra-hepatically. When tumor mass formed, activated CTLs were intravenously transferred into the tumor-bearing mice, that were given the drinking water containing 2% dextran sulfate sodium (DSS) for acute colitis induction. Tumor growth, infiltration of two exhausted CTL subsets, and the CTL interaction with tumor vascular endothelium were examined. Results Acute colitis dampened CTL-mediated antitumor effects, correlating with IL-17A elevation in the inflamed intestine. In the tumor bed, stem-like exhausted CTLs, which were defined as PD-1 + Slamf6 + Tim3 − , expressed higher IL-17A receptor heterodimers and lower leukocyte function-associated antigen-1 (LFA-1) than terminally exhausted CTLs did, that were defined as PD-1 + Slamf6 − Tim3 + . IL-17A stimulation reduced LFA-1 surface expression on stem-like exhausted CTLs and the counterpart ICAM-1 (intracellular adhesion molecule-1) on tumor vascular endothelium. IL-17A stimulation suppressed the extravasation across tumor vascular endothelium and self-renewal of stem-like, not the terminally exhausted CTLs. Administration of anti-IL-17A neutralizing antibody to the colitis mice restored the CTL tumor infiltration and enhanced anti-PD-1 treatment efficacy against tumors. In 33 hepatocellular carcinoma patients being treated with anti-PD-1 plus antibody against vascular endothelial growth factor, disease progression of 15 patients, that exhibited serum IL-17A increase 24 h post-therapy as compared to pre-therapy level, was poorer than that of 18 patients that exhibited serum IL-17A no-increase. Conclusions Abnormal generation of IL-17A mainly repressed tumor infiltration of stem-like exhausted CTLs. ICB-based immunotherapeutic efficacy could be upgraded with administration of anti-IL-17A, when treatment-related IL-17A elevation occurred due to tissue damage, such as acute colitis.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Angiogenesis / Anti-cancer therapy-related colitis / Antibodies / Anticancer properties / Antigens / Antitumor activity / Biomedicine / Cancer therapies / Care and treatment / CD8 antigen / Cells / Cloning / Colitis / Complications and side effects / Cytotoxicity / Damage / Dextran / Dextran sulfate / Dextrans / Disease progression / Drinking water / Effectiveness / Endothelium / Experiments / Extravasation / Growth factors / Health aspects / Hepatocellular carcinoma / ICB-immunotherapy / Immune checkpoint inhibitors / Immunotherapy / Infiltration / Inflammation / Inflammatory bowel disease / Intercellular adhesion molecule 1 / Interleukin 17A / Interleukins / Intestine / LFA-1 antigen / Liver cancer / Lymphocytes / Lymphocytes T / Medicine / Medicine & Public Health / Metastases / Pathogenesis / Patient outcomes / PD-1 protein / Peptides / Research Article / Statistical analysis / Stem-like exhausted CD8+ T cells / Stimulation / Tumor cell lines / Tumor vascular endothelium / Tumors / Vascular endothelial growth factor